Find any stock by ticker or company name
Barcha huquqlar himoyalangan.
43.18
0.00 (0.00%)
Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Transcript
Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Prepared Remarks Transcript
Hikma Pharmaceuticals LON: HIK said it reiterated its full-year guidance after reporting higher sales, earnings and per-share profit in its 2026 interim results, while outlining further investment in manufacturing capacity, research and development, and commercial capabilities.
There is no data to display
